http://www.aldeyra.com
Aldeyra Therapeutics, Inc. Company Intro
Learn more about Aldeyra Therapeutics, devoted to inventing, developing, and commercializing next-generation medicines that treat immune-mediated disease.
Industry
Healthcare
Aldeyra Therapeutics, Inc. Headquaters
131 Hartwell Avenue
Lexington,02421
United States
Aldeyra Therapeutics, Inc. Share price
17 May 2023 12:45 GMT
$10.07
-0.14 (-1.37 %)
Aldeyra Therapeutics, Inc. Market cap
$586.936 M
WMC RANKING
2023
Aldeyra Therapeutics, Inc. # 383
BiotechnologyLatest Aldeyra Therapeutics, Inc. News
26 May 2023
Anterior Uveitis Treatment Market worth $xx billion by 2030 ...
Novartis AG, Santen Pharmaceutical Co., AbbVie Inc., Eyegate Pharmaceuticals Inc., Clearside Biomedical Inc., Aldeyra Therapeutics Inc., Aciont Inc.,...
26 May 2023
Anterior Uveitis Treatment Market worth $xx billion by 2030 ...
Novartis AG, Santen Pharmaceutical Co., AbbVie Inc., Eyegate Pharmaceuticals Inc., Clearside Biomedical Inc., Aldeyra Therapeutics Inc., Aciont Inc.,...
25 May 2023
Thrivent Financial for Lutherans Grows Stock Holdings in ...
Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients...
WMC Market Score
WMC Market to Revenue Score
Aldeyra Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aldeyra Therapeutics, Inc. | USD | $0 | $35,859 | $-38,975 | $5,869M | 383 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aldeyra Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Post vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Aldeyra Therapeutics, Inc. | 0 | 1.08 | 0.00 | 0 | 0 | 0 | 0.47 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
